Your browser is no longer supported. Please, upgrade your browser.
MDT Medtronic plc monthly Stock Chart
MDT [NYSE]
Medtronic plc
IndexS&P 500 P/E28.96 EPS (ttm)3.50 Insider Own0.10% Shs Outstand1.34B Perf Week4.71%
Market Cap131.35B Forward P/E18.13 EPS next Y5.59 Insider Trans0.52% Shs Float1.34B Perf Month4.25%
Income4.73B PEG3.01 EPS next Q0.15 Inst Own84.70% Short Float0.58% Perf Quarter7.96%
Sales28.91B P/S4.54 EPS this Y2.30% Inst Trans-0.13% Short Ratio1.36 Perf Half Y-13.30%
Book/sh37.84 P/B2.68 EPS next Y54.11% ROA5.20% Target Price110.17 Perf Year0.36%
Cash/sh8.44 P/C12.00 EPS next 5Y9.62% ROE9.40% 52W Range72.13 - 122.15 Perf YTD-10.72%
Dividend2.32 P/FCF42.01 EPS past 5Y7.70% ROI6.70% 52W High-17.08% Beta0.65
Dividend %2.29% Quick Ratio1.70 Sales past 5Y7.40% Gross Margin67.90% 52W Low40.43% ATR2.06
Employees90000 Current Ratio2.10 Sales Q/Q-26.40% Oper. Margin15.10% RSI (14)63.13 Volatility1.98% 1.88%
OptionableYes Debt/Eq0.49 EPS Q/Q-47.40% Profit Margin16.60% Rel Volume0.65 Prev Close102.09
ShortableYes LT Debt/Eq0.43 EarningsAug 25 BMO Payout60.50% Avg Volume5.69M Price101.29
Recom2.00 SMA203.76% SMA506.26% SMA200-1.22% Volume3,714,838 Change-0.78%
May-14-20Downgrade DZ Bank Buy → Hold $92
Mar-30-20Downgrade Needham Strong Buy → Buy $134 → $109
Mar-25-20Upgrade DZ Bank Hold → Buy $90
Mar-05-20Initiated Citigroup Buy $124
Feb-13-20Initiated Goldman Sell $118
Jan-08-20Initiated SunTrust Buy $130
Jan-02-20Upgrade Guggenheim Neutral → Buy $135
Jun-05-19Upgrade Wells Fargo Market Perform → Outperform
Feb-04-19Reiterated Needham Strong Buy $120 → $117
Jan-03-19Initiated Deutsche Bank Buy $99
Jan-02-19Downgrade Citigroup Buy → Neutral
Dec-19-18Upgrade JP Morgan Neutral → Overweight
Nov-28-18Initiated UBS Buy
Oct-16-18Initiated Barclays Overweight $113
Aug-27-18Reiterated Argus Buy $95 → $108
Aug-22-18Reiterated Stifel Hold $87 → $96
Aug-13-18Upgrade Needham Buy → Strong Buy $103 → $119
Jun-27-18Initiated Bernstein Mkt Perform $88
Jun-06-18Resumed William Blair Mkt Perform
Jun-06-18Reiterated Needham Buy $97 → $103
Aug-13-20 10:35AM  
08:17AM  
07:57AM  
Aug-11-20 11:00AM  
09:00AM  
Aug-05-20 07:00AM  
Aug-03-20 12:22PM  
07:00AM  
Aug-02-20 07:33AM  
Jul-27-20 05:50PM  
Jul-22-20 09:00AM  
Jul-17-20 07:18PM  
03:59PM  
Jul-15-20 11:01AM  
10:34AM  
07:30AM  
06:21AM  
02:30AM  
02:30AM  
Jul-14-20 09:29AM  
Jul-13-20 07:00PM  
01:32PM  
Jul-11-20 07:13AM  
Jul-09-20 10:05AM  
09:00AM  
Jul-08-20 03:52PM  
01:17PM  
12:29PM  
11:30AM  
10:27AM  
Jul-07-20 09:15AM  
09:00AM  
Jul-06-20 10:00AM  
Jul-05-20 08:11AM  
Jul-02-20 04:47PM  
Jul-01-20 05:50PM  
Jun-29-20 07:47AM  
Jun-28-20 11:03PM  
Jun-26-20 09:14AM  
Jun-25-20 05:50PM  
11:05AM  
11:00AM  
10:14AM  
08:00AM  
Jun-24-20 06:00AM  
Jun-23-20 10:52AM  
Jun-22-20 04:43PM  
09:00AM  
Jun-20-20 11:30AM  
Jun-19-20 10:14AM  
Jun-18-20 03:15PM  
03:07PM  
08:44AM  
08:41AM  
08:30AM  
Jun-17-20 09:19AM  
Jun-16-20 12:00PM  
Jun-15-20 09:00AM  
06:54AM  
02:28AM  
Jun-14-20 06:25AM  
04:04AM  
Jun-13-20 11:00AM  
Jun-12-20 05:30PM  
05:00PM  
11:46AM  
Jun-11-20 09:00AM  
Jun-09-20 03:00PM  
11:30AM  
10:23AM  
Jun-08-20 12:00PM  
Jun-05-20 09:00AM  
Jun-03-20 11:00AM  
Jun-02-20 01:00PM  
11:21AM  
11:05AM  
May-29-20 11:00AM  
May-26-20 03:21PM  
12:59PM  
09:02AM  
May-24-20 07:05AM  
May-22-20 11:00AM  
09:25AM  
09:00AM  
06:07AM  
May-21-20 05:01PM  
04:16PM  
02:51PM  
02:00PM  
12:18PM  
08:05AM  
07:47AM  
06:45AM  
May-20-20 07:43AM  
May-19-20 10:00AM  
May-18-20 04:21PM  
03:19PM  
12:00PM  
11:43AM  
May-16-20 09:15AM  
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Surface Carol ASVP, Chief HR OfficerMay 29Sale97.722,000195,44047,443Jun 02 05:39 PM
OLEARY DENISE MDirectorApr 03Option Exercise44.131,81380,00866,544Apr 07 06:17 PM
ISHRAK OMARChairman & CEOFeb 20Buy113.688,771997,087605,190Feb 24 08:56 AM
Kuntz RichardSVP & Chief Medical & ScienceDec 24Option Exercise54.5542,7702,333,054109,571Dec 26 05:36 PM
Kuntz RichardSVP & Chief Medical & ScienceDec 24Sale113.5850,8565,776,10171,013Dec 26 05:36 PM
ANDERSON RICHARD HDirectorDec 06Buy113.295,000566,45095,231Dec 09 05:36 PM
WHITE ROBERT JOHNEVP & President MITGDec 02Option Exercise61.2652,1663,195,798104,234Dec 03 04:25 PM
WHITE ROBERT JOHNEVP & President MITGDec 02Sale110.6252,1665,770,82952,068Dec 03 04:25 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 15Option Exercise38.8136,8741,431,080225,136Nov 18 05:31 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 15Sale111.2536,8744,102,092188,262Nov 18 05:31 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 14Option Exercise40.412,10284,932189,464Nov 15 05:49 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 14Sale109.772,102230,731188,262Nov 15 05:49 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 01Option Exercise38.9038,9761,516,012226,036Nov 04 06:26 PM
WHITE ROBERT JOHNEVP & President MITGNov 01Option Exercise36.3452,1651,895,47895,158Nov 04 06:28 PM
WHITE ROBERT JOHNEVP & President MITGNov 01Sale109.3352,1655,702,99552,068Nov 04 06:28 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascNov 01Sale109.5038,9764,267,872188,262Nov 04 06:26 PM
Surface Carol ASVP, Chief HR OfficerOct 11Option Exercise80.8584,2076,808,395121,920Oct 15 04:37 PM
WHITE ROBERT JOHNEVP & President MITGOct 01Option Exercise28.1752,1651,469,549104,082Oct 02 04:54 PM
Kuntz RichardSVP & Chief Medical & ScienceSep 27Sale107.5121,4252,303,49378,816Sep 30 05:52 PM
Lenehan James TDirectorSep 25Option Exercise44.131,81380,00855,464Sep 26 06:20 PM
HAKAMI HOOMANEVP & Group President DiabetesSep 10Option Exercise85.7072,8776,245,60458,015Sep 12 05:55 PM
HAKAMI HOOMANEVP & Group President DiabetesSep 10Sale107.3182,8778,893,71230,761Sep 12 05:55 PM